Literature DB >> 33287946

Review of current pathways to wait-listing for kidney transplantation for Aboriginal and Torres Strait Islander peoples with end-stage kidney disease in the Top End of Northern Australia.

Sandawana W Majoni1, Kerry Dole2, Jaquelyne T Hughes3, Charles Pain4.   

Abstract

Published evidence confirms poor access to wait-listing for kidney transplantation for Aboriginal and Torres Strait Islander Australians from the Northern Territory. This study aimed to identify the practical causes and recommend improvement. Pathways to wait-listing for a kidney transplant were reviewed to identify potential barriers. Processes were mapped to identify potential problem areas, provide comparison of the actual versus the ideal, identify where data needed collecting and provide clear presentation of the processes. Staff involved in the work-up of patients going for wait-listing were asked to list the barriers. Data were collected for patients from the transplant database between 1 January 2017 to 31 August 2018. Quality improvement statistical processes and charts were used to analyse and present the results. There were 102 patients in the transplant work-up process; 81.4% were Aboriginal and Torres Strait Islander, 71.6% were progressing with the work-up, 28.4% were on-hold. Of the 29 patients on hold, 92.9% were Aboriginal and Torres Strait Islander. Causes of delays to wait-listing included: failure to attend appointments due to competing priorities and communication barriers, access and navigating complex pathways to specialist services, transport, co-morbidities requiring multiple tests and multiple specialty services, and pressures on dialysis and hospital bed capacity. In conclusion, barriers to wait-listing for kidney transplantation for Aboriginal and Torres Strait Islander Australians are complex and can be addressed by redesigning healthcare provision, including increasing the Aboriginal and Torres Strait Islander workforce to provide education and patient navigation of the healthcare system and improve communication, streamlining investigations and coordinating specialist services.

Entities:  

Mesh:

Year:  2021        PMID: 33287946     DOI: 10.1071/AH20011

Source DB:  PubMed          Journal:  Aust Health Rev        ISSN: 0156-5788            Impact factor:   1.990


  1 in total

1.  Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up.

Authors:  Paul J Clark; Patricia C Valery; James Ward; Simone I Strasser; Martin Weltman; Alexander Thompson; Miriam T Levy; Barbara Leggett; Amany Zekry; Julian Rong; Peter Angus; Jacob George; Steven Bollipo; Bruce McGarity; William Sievert; Gerry Macquillan; Edmund Tse; Amanda Nicoll; Amanda Wade; Geoff Chu; Damian Harding; Wendy Cheng; Geoff Farrell; Stuart K Roberts
Journal:  BMC Gastroenterol       Date:  2022-07-11       Impact factor: 2.847

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.